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A monoclonal antibody, 5H4, that recognizes human herpesvirus 7 (HHV-7) was used in Western analysis to probe
HHV-7-infected SupT1 cells. This antibody recognizes a 40-kDa virus-specific polypeptide that is expressed in the absence
of viral DNA synthesis. By screening a lgt11 HHV-7 cDNA library, the gene encoding the protein was identified as the U27
open reading frame previously reported [J. Virol. (1996) 70, 5975–5989]. Immunofluorescent studies showed a punctate
nuclear localization of the protein in both HHV-7-infected cells and transfected cells. A computer program predicted two
classic nuclear localization signals (NLSs) in the middle and C-terminal regions of the protein. A C-terminal deletion mutant
of the protein could not enter the nucleus, whereas green fluorescent protein or maltose binding protein fused to the
C-terminal region of the protein was transported into the nucleus. These findings demonstrate that the predicted C-terminal,
but not middle, NLS of the protein actually function as NLS. In addition, nuclear transport of a maltose binding protein-fusion
protein containing the C-terminal NLS of the U27 protein was inhibited by both wheat germ agglutinin and a Q69L Ran-GTP
mutant, indicating that the U27 protein is transported into the nucleus from the cytoplasm by means of classic nuclear
transport machinery. Interestingly, this NLS motif is highly conserved at the C-termini of all herpesvirus DNA polymerase
processivity factors that have been examined. © 2000 Academic Press
a
eINTRODUCTION
Human herpesvirus 7 (HHV-7) is an ubiquitous, T lym-
photropic b-herpesvirus that was first isolated in 1990 from
D41 lymphocytes of a healthy adult (Frenkel et al., 1990).
eroepidemiological studies have indicated that the pri-
ary infection with HHV-7 occurs early in childhood, al-
hough the age of infection with HHV-7 appears to be
omewhat later than that with HHV-6, and that HHV-7 is
nother causative agent of exanthem subitum, a common
hildhood disease (Tanaka et al., 1994; Tanaka-Taya et al.,
996; Wyatt et al., 1991). Molecular biological and immuno-
ogical studies have demonstrated that HHV-7 belongs to
he b-herpesvirus family and that HHV-6 is the most closely
related virus to HHV-7 of the members of this family, but
nevertheless they differ from each other significantly
(Berneman et al., 1992; Foa-Tomasi et al., 1994; Nakagawa
et al., 1997; Nicholas 1996; Wyatt et al., 1991).
Among herpesviruses, DNA polymerase processivity
factors are highly conserved (Gompels et al., 1995; Nich-
olas, 1996; Russo et al., 1996) and have been shown to
be essential for viral DNA replication (Gao et al., 1993;
Johnson et al., 1991; Ripalti et al., 1995). A DNA polymer-
ase processivity factor forms a complex with its viral1 To whom reprint requests should be addressed. Fax: 81-6-6879-
329.
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394DNA polymerase and increases the activity of the poly-
merase (Digard et al., 1993; Lin et al., 1998; Lin and
Ricciardi, 1998; Weiland et al., 1994), as do the prolifer-
ating cell nuclear antigen of yeast, the b subunit of
Escherichia coli DNA polymerase III holoenzyme, and
gene product 45 of T4 phage (Kuriyan and O’Donnell,
1993). However, the structure of these enzymes and the
mechanism by which they confer processivity on their
polymerase remain unclear. So far, it has been demon-
strated that the C-terminal region of DNA polymerase
processivity factor is dispensable for binding to and
activating DNA polymerase in vitro and in vivo (Digard et
l., 1993; Gao et al., 1993; Lin and Ricciardi, 1998; Tenny
t al., 1993; Weiland et al., 1994).
In this report, we characterize the general features
(molecular weight, time course of expression, localiza-
tion in infected cells) of the HHV-7 U27 protein, a ho-
molog of herpesvirus DNA polymerase processivity fac-
tor, and present compelling evidence that the extreme
C-terminal region of the protein functions as a Ran-
dependent nuclear localization signal.
RESULTS AND DISCUSSION
Identification of HHV-7 cDNA clones that react with
the 5H4 monoclonal antibodyA series of monoclonal antibodies were established
against HHV-7 for use in studying viral proteins. In this
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395IDENTIFICATION OF HHV-7 U27 NLSstudy, one of them, 5H4, was characterized by the fol-
lowing experiments.
First, to identify the gene encoding the protein recog-
nized by the 5H4 monoclonal antibody, a lgt11 HHV-7
cDNA expression library was constructed. On screening,
several immunoreactive clones were recognized, and
the inserted cDNAs were amplified by PCR and cloned
into a plasmid vector, pCRII (Invitrogen, San Diego, CA).
Determination of their DNA sequences revealed that
cloned cDNAs contained the U27 open reading frame
(ORF), which encodes for a homolog of herpesvirus DNA
polymerase processivity factor (Nicholas, 1996).
Expression of the U27 ORF
To investigate the size of the U27 protein, HHV-7-
infected SupT1 cell proteins were analyzed by Western
blotting using the monoclonal antibody 5H4 as a probe.
As shown in Fig. 1A, a polypeptide with an apparent
molecular mass of 40 kDa was detected in HHV-7-in-
fected cells (lane 1) but not in uninfected cells (lane 2).
The size of this protein is in agreement with the pre-
FIG. 1. (A) Western blot analysis of HHV-7-infected cells with mono-
clonal antibody 5H4. Lane 1, HHV-7-infected SupT1 cells. Lane 2,
mock-infected SupT1 cells. Lane M, molecular weight markers. (B)
Time course of HHV-7 U27 protein synthesis. Mock-infected and HHV-
7-infected SupT1 cells were collected 0, 24, 48, 72, and 96 h p.i. and
then probed with 5H4 (upper panel) or 24G7 (lower panel) by Western
blot analysis. (C) PFA treatment of HHV-7-infected cells. SupT1 cells
were pretreated with PFA (500 mg/ml) 1 h before infection, infected with
HV-7 (KHR), and then cultured for 72 h in the presence of PFA (1). As
control, untreated cells were also prepared (2). PFA-treated and
ntreated cells were collected 72 h p.i. and analyzed for the expression
f HHV-7 U27 protein and viral tegument protein (U14 product) with 5H4
left panel) or 24G7 (right panel), respectively. (D) Fractionation of
HV-7 U27 protein. Proteins from HHV-7-infected SupT1 cells were
eparated into cytoplasmic (lane C) and nuclear (lane N) fractions, and
he presence of the HHV-7 U27 protein and the heat shock protein
SP90b was ascertained with 5H4 (left panel) or anti-HSP90b (right
anel), respectively.dicted size (41.6 kDa) of the protein encoded by the U27
ORF. Immunoprecipitation analysis of the protein pre-
e
(pared from HHV-7-infected cells also showed a virus-
specific 40-kDa protein (data not shown).
The time course of the U27 protein expression was
examined by Western analysis of HHV-7-infected SupT1
cell lysates prepared at different times after infection. As
shown in Fig. 1B, the U27 protein was first detectable at
24 h postinfection (p.i). In comparison, a tegument pro-
tein was first detectable at 48 h p.i with the monoclonal
antibody 24G7, which is specific for HHV-7 U14 protein
(Stefan et al., 1997). The expression of U27 earlier in
infection than the viral tegument protein is consistent
with the predicted role of the U27 protein in viral DNA
replication.
To study the synthesis of the U27 protein with respect
to the replicative cycle of HHV-7, Western blotting using
5H4 was performed on HHV-7-infected SupT1 cell ly-
sates exposed to a potent viral replication inhibitor,
phosphonoformic acid (PFA). As shown in Fig. 1C, the
expression of U27 was detectable even in the presence
of PFA, but the expression of the tegument protein (U14
product) was completely inhibited by PFA. This result
indicates that the expression of the U27 protein, but not
the U14 protein, is independent of the viral DNA synthe-
sis.
Next, to determine the intracellular distribution of U27,
proteins from HHV-7-infected cells were separated into
nuclear and cytoplasmic fractions, as described in Ma-
terials and Methods, and analyzed by Western blotting
using the monoclonal antibody 5H4 and anti-HSP90b.
The U27 protein was detected only in the nuclear fraction
(Fig. 1D, left), suggesting that it is predominantly local-
ized to the nucleus of HHV-7-infected cells, which is in
agreement with its predicted role in viral DNA replica-
tion. On the other hand, almost all of the HSP90b, a
ytoplasmic marker, was detected in the cytoplasmic
raction, indicating that the cell extracts were success-
ully fractionated (Fig. 1D, right).
ocalization of the U27 protein in HHV-7-infected
r transfected cells
For further characterization of the subcellular localiza-
ion of the U27 protein, its expression was investigated
y indirect immunofluorescence using 5H4. As shown in
ig. 2A, the nuclei of HHV-7-infected SupT1 cells exhib-
ted a strong punctate pattern (panel a) as previously
escribed for HHV-6 (Agulnick et al., 1993). Interestingly,
H4 reacted not only with HHV-7-infected SupT1 but also
ith HHV-6-infected MT-4 cells (Fig. 2A, panels a and b).
n the other hand, the control monoclonal antibody
HV3, which recognizes gH of HHV-6B (Okuno et al.,
990; Takeda et al., 1997), reacted only with MT-4 cells
nfected with HHV-6B (Fig. 2A, panels e and f). The
pecificity of the primary and secondary antibodies was
vident by the absence of reactivity to uninfected cells
Fig. 2A, panels c and d). Cross-reactions of anti-HHV-7
N396 TAKEDA ET AL.monoclonal antibodies with HHV-6 have been previously
reported (Berneman et al., 1992; Foa-Tomasi et al., 1994;
akagawa et al., 1997; Wyatt et al., 1991).
COS7 cells were also transfected with a plasmid,
pcDNA/7U27, capable of expressing a full-length U27
protein, and 48 h later, U27 protein and the nuclei were
stained with the monoclonal antibody 5H4 and Hoechst
33258, respectively. As shown in Fig. 2B, U27 localized to
the nucleus of transiently transfected cells and the nu-
cleoli were not stained; these results were the same as
previously reported for HHV-6 (Agulnick et al., 1993). This
result is consistent with the results of the fractionation
experiment (Fig. 1D) and of the immunofluorescent assay
(IFA) of HHV-7-infected SupT1 cells (Fig. 2A). The immu-
nofluorescent result from the transfected COS7 cells also
revealed that nuclear translocation of U27 protein oc-
curred in the absence of other viral proteins. However,
there was a striking difference between the expression
patterns of U27 protein in virally infected SupT1 cells and
transiently transfected COS7 cells (Figs. 2A and 2B),
although confocal microscopy analysis showed a gran-
ular nuclear localization of the U27 protein in the tran-
siently transfected cells (data not shown). The expres-
sion pattern of U27 protein may depend on the absence
or the presence of other viral proteins, which form a
FIG. 2. (A) IFA of HHV-7-infected cells with monoclonal antibody 5H4.
HHV-7-infected SupT1 cells (a and e) and HHV-6-infected MT-4 cells (b
and f) were stained with monoclonal antibody 5H4 (a and b) or OHV3
(e and f). Mock-infected SupT1 and MT-4 cells were also stained with
5H4 (c and d) (B) Intracellular localization of the HHV-7 U27 protein in
transfected cells. COS7 cells were transfected with the pcDNA/7U27
and cultured for 24 h in DMEM with 10% FCS. The localization of HHV-7
U27 protein was examined by IFA with monoclonal antibody 5H4 (a). In
panel b, the same cells were stained with Hoechst 33258.replication compartments, or the cell type where it was
expressed.Prediction of a nuclear localization signal
Because the nuclear localization of U27 (Fig. 2B) sug-
gested that U27 contains a nuclear localization signal
(NLS) in its amino acid sequence, we used a computer
program (PSORT II, http://nibb.ac.jp:8000/) to search the
U27 sequence for putative NLSs. The computer program
was able to predict two putative classic NLSs (type pat7)
in the U27 protein (Fig. 3A). These NLS sequences start
with proline, which is followed within three residues by a
basic segment where three of the next four residues are
lysines or arginines. One NLS was predicted to reside
between residues 176 and 182 (PVTKNKR); another is
present in the extreme C-terminal domain (residues 355–
361, PNSKRQR). In addition, the amino acid sequence
alignment of the HHV-7, HHV-6, and HCMV DNA poly-
merase processivity factor homologs showed that the
FIG. 3. (A) Amino acid sequence alignment of the HHV-7, HHV-6, and
HCMV DNA polymerase processivity factors. Predicted NLSs are indi-
cated by shaded boxes. Casein kinase II site is boxed (unshaded). (B)
Predicted NLS sites for herpesvirus DNA polymerase processivity fac-
tor homologs. NLSs are indicated by shaded boxes. The accession
numbers of the sequences for the following are given in parentheses:
HSV-1 (M19121), HSV-2 (Z86099), VZV (X04370), PRV (M94355), EHV-4
(AF030027), HCMV (X17403), HHV-6 (X83413), HHV-7 (U43400), EBV
(V01555), HHV-8 (U75698), HVS2 (X64346), and MCMV-68 (Y09060).
397IDENTIFICATION OF HHV-7 U27 NLStwo putative NLSs are conserved among these human
b-herpesviruses (Fig. 3A). Interestingly, a strong casein
kinase II phosphorylation site was also found upstream
of the C-terminal NLS of these herpesviruses (Fig. 3A),
suggesting that phosphorylation of this site may affect
nuclear translocation of the protein, as previously de-
scribed (Rihs et al., 1991). Furthermore, this classic NLS
motif was conserved at the extreme C-termini of all of the
other herpesvirus DNA polymerase processivity factors
that were examined (Fig. 3B).
Mapping of the NLS activity of U27 protein
To determine whether one or both of the U27 NLSs
were functional, we constructed a C-terminal deletion
mutant of the U27 protein (Fig. 4A), which lacked the
C-terminal NLS sequence. Because the monoclonal an-
tibody 5H4 could not detect the C-terminal deletion mu-
tant (data not shown), an His-Xpress epitope sequence
was added at the N-terminus of the protein for detection
with the anti-Xpress antibody (Invitrogen). The His-
Xpress epitope-tagged full-length U27 protein, from the
plasmid pHis/7U27, localized to the cell nucleus, as did
U27 protein alone (Fig. 4B, panels b and a, respectively).
Thus epitope tagging dose not alter the distribution of
the protein in transiently transfected cells. The C-termi-
nal deletion mutant with its epitope tag, His/U27(1-250),
did not accumulate in the nucleus (Fig. 4B, panel c),
indicating that the C-terminal region of U27 is required
for the translocation of the protein from the cytoplasm to
the nucleus. On the other hand, one of the two predicted
NLSs was present in the deletion mutant (Fig. 3A, resi-
dues 176–182) and did not function as an NLS, although
it was conserved among human b-herpesviruses. To
confirm the NLS activity of the C-terminal region of U27,
we expressed a green fluorescent protein (GFP)-fusion
protein fused to the C-terminal region of U27 protein,
corresponding to amino acid residues 251–364, in trans-
fected cells. As shown in Fig. 4B, the GFP-fusion protein
completely localized to the nucleus (panel e), whereas
GFP alone was observed in both the nucleus and cyto-
plasm (panel d). These findings demonstrate that the
C-terminal region of U27 protein contains a functional
NLS.
To further characterize the C-terminal domain containing
the NLS, various C-terminal regions of U27 protein were
expressed as GFP-fusion proteins in transfected cells, and
the distributions of the proteins were analyzed. GFP/
7U27(251-364), GFP/7U27(276-364), and GFP/7U27(301-
364) localized to the nucleus (Fig. 4B, panels e–g, respec-
tively). Cytoplasmic localization was observed in the case
of GFP/7U27(326-364) and GFP/7U27(351-364), although in-
tense nuclear fluorescence was also detected (panels h
and i). These data suggest that the last 14-amino-acid
stretch of U27 protein is required for the nuclear localization
in vivo. Recently, Epstein–Barr virus DNA polymerase pro-cessivity factor encoded by BMRF1 was shown to contain
an NLS in the last 26 amino acids (Zhang et al., 1999).
Gao et al. (1993) reported that HSV-1 mutant deleted
for the C-terminal third of the DNA polymerase proces-
sivity factor, including the C-terminal NLS, replicated
similarly to the wild-type virus in cultured cells. Although
the C-terminal region of DNA polymerase processivity
factor of HSV-1 is dispensable in cultured cells, its func-
tion in infected individuals remains unknown. Because
the number of NLSs correlated with the relative uptake of
conjugates with NLSs into the nucleus (Dworetzky et al.,
1988), the C-terminal NLS may be required for the effi-
cient viral replication in infected individuals. In addition,
it was recently reported that EBV DNA polymerase pro-
cessivity factor functioned as a transactivator and that
the C-terminal part of the protein was required for the
transactivation (Zhang et al., 1999).
Wheat germ agglutinin and Q68L Ran-GTP mutant
inhibit nuclear transport via the NLS
To exclude the possibility that GFP fusion protein with
the C-terminal region of U27 entered the cell nucleus by
passive diffusion, we examined whether wheat germ
agglutinin (WGA) blocked nuclear localization. WGA se-
lectively inhibits the active nuclear transport of proteins
by binding to a component of the nuclear pore complex
(NPC) but does not block nuclear translocation of small
molecules by passive diffusion (Finlay et al., 1987;
Yoneda et al., 1987). We constructed a fusion protein with
maltose binding protein (MBP) fused in-frame with the
C-terminal region of U27, containing the sequence be-
tween amino acids 251 and 364 (Fig. 4A). The purified
fusion protein was microinjected into the cytoplasm of
HeLa cells in the absence or presence of WGA. As
shown in Fig. 4B (panel k), the microinjected MBP-fusion
protein, MBP/7U27(251-364), translocated into the nu-
cleus, but the protein did not enter the nucleus in the
presence of WGA (panel l). MBP alone was not localized
to the nucleus, probably because of its molecular size (51
kDa) and the absence of an NLS (panel j). These findings
indicate that MBP-fusion protein was transported to the
nucleus through the NPC and confirm that the C-terminal
region of U27 protein is responsible for its nuclear trans-
location.
The Ran protein has been shown to be required for
classic NLS-dependent nuclear transport (Moore and
Blobel, 1993). To determine whether Ran is required for
the nuclear transport of the HHV-7 U27 protein, we mi-
croinjected both the MBP/7U27(251-364)-fusion protein
and a mutated Ran protein, Q69L Ran-GTP, which is
deficient in GTP hydrolysis (Palacios et al., 1996), into the
cytoplasm of HeLa cells and immunochemically as-
sessed the expression pattern of MBP/7U27(251-364). As
shown in Fig. 4B (panel m), MBP/7U27(251-364) did not
enter the nucleus in the microinjected cells. This result
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the NLS is Ran dependent and requires the hydrolysis of
GTP.
In summary, we found that HHV-7 U27 is a 40-kDa
nuclear protein that is synthesized in the absence of viral
DNA synthesis. We mapped the functional NLS of U27 to
the extreme C-terminus of the protein and showed its
activity to be dependent on Ran. Interestingly, a similar
NLS motif is conserved at the C-termini of the other
herpesvirus DNA polymerase processivity factors that
we tested.
MATERIALS AND METHODS
Viruses and cells
HHV-7 (strain KHR) and HHV-6 (strain HST) were prop-
agated in SupT1 and MT-4 continuous T-cell lines, re-
spectively. Both cell lines were cultured in RPMI 1640
medium containing 10% heat-inactivated fetal calf serum
(FCS). COS7 and HeLa cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% or 5% FCS.
Antibodies
Hybridoma clones producing anti-HHV-7 monoclonal
FIG. 4. (A) Construction of expression plasmids for the full-length HHV
and MBP with the C-terminal region of HHV-7 U27. PCR products, enc
cloned into an expression vector, pcDNA/3.1(1), pcDNA3.1/His C, pEGF
NLS of HHV-7 U27. COS7 cells were transfected with pcDNA/7U27 (pa
pGFP/7U27(251-364) (panel e), pGFP/7U27(276-364) (panel f), pGFP/7U
(panel i). After 24 h, cells were stained with monoclonal antibody 5H4 (
fluorescence microscopy. GFP (panel d) and the GFP-fusion protein (pa
The MBP-fusion protein MBP/7U27(251-364) was microinjected into HeL
k) or presence (panel l) of WGA or the Q69L Ran/GTP mutant (panel m)
microinjected into the cytoplasm in the absence of WGA or Ran mutaantibodies were established from splenocytes of mice
immunized with KHR-infected SupT1 cells as describedpreviously (Nakagawa et al., 1997). The monoclonal an-
tibodies 5H4 and 24G7 recognize the U27 and U14 pro-
teins of HHV-7, respectively. The monoclonal antibodies
anti-Xpress and anti-HSP90b and the rabbit anti-MBP
ntiserum were purchased from Invitrogen, Santa Cruz
Santa Cruz, CA), and New England Biolabs (Beverly,
A), respectively.
onstruction and screening of cDNA library
Polyadenylated RNA was isolated from HHV-7-infected
upT1 cells using the Fast-Track system (Invitrogen),
everse transcribed with the Superscript Choice System
GIBCO BRL, Grand Island, NY), and then used to gen-
rate a lgt11 cDNA library. This library was screened
with the 5H4 monoclonal antibody using picoBlue immu-
noscreening kit (Stratagene, La Jolla, CA), and several
positive plaques were identified. The HHV-7 cDNA insert
in the lambda DNA was amplified by PCR, and the
amplified products were cloned into the pCRII (Invitro-
gen), TA-cloning vector, and sequenced by the dideoxy-
nucleotide chain termination method.
IFA
For HHV-7- and HHV-6-infected cells, indirect IFA was
protein, the C-terminal deletion mutant, and the in-frame fusion of GFP
he full-length, N-terminal, and C-terminal regions of HHV-7 U27, were
r pMAL-c2 as described in Materials and Methods. (B) Mapping of an
pHis/7U27 (panel b), pHis/7U27(1-250) (panel c), pEGFP-C1 (panel d),
-364) (panel g), pGFP/7U27(326-364) (panel h), or pGFP/7U27(351-364)
) and the anti-Xpress antibody (panels b and c) and then examined by
i) were directly observed by fluorescence microscopy without staining.
cytoplasm and assayed for nuclear translocation in the absence (panel
ing with anti-MBP rabbit serum. As a control, the MBP alone was also
el j).-7 U27
oding t
P-C1, o
nel a),
27(301
panel a
nels e–
a cellperformed as described previously (Takeda et al., 1996).
For HeLa cells microinjected with the MBP-fusion pro-
cc
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399IDENTIFICATION OF HHV-7 U27 NLStein, cells were washed with PBS, fixed with 3.7% form-
aldehyde in transport buffer (20 mM HEPES, pH 7.4, 110
mM potassium acetate, 2 mM magnesium acetate, 5 mM
sodium acetate, 0.5 mM EGTA) for 10 min at room tem-
perature (R.T.), and permeabilized with 0.5% Triton X-100
in PBS for 5 min at R.T. Cells were incubated in blocking
buffer (3% skim milk in PBS) for 20 min at R.T. and then
reacted with anti-MBP rabbit serum in blocking buffer.
After washing with PBS three times for 5 min each, cells
were incubated in blocking buffer supplemented with
cy3-labeled anti-rabbit IgG antibodies for 30 min at R.T.
After washing as above, cells were observed using flu-
orescence microscopy.
For COS7 cells transfected with the GFP-fusion plas-
mid, cells were observed directly using a fluorescence
microscope.
Western blot analysis
Protein samples were fractionated by SDS–PAGE and
electrophoretically transferred to a polyvinylidene difluo-
ride (PVDF) membrane (BioRad, Hercules, CA). The
membrane was incubated in blocking buffer (0.05%
Tween 20, 5% skim milk in TBS) for 1 h with shaking at
R.T. to block the nonspecific binding sites. Primary anti-
body incubation was carried out for 1 h at R.T. with
shaking in antibody dilution buffer (0.05% Tween 20, 2%
skim milk in TBS) with 1:500 dilution of monoclonal an-
tibody. After washing (0.05% Tween 20 in TBS) three
times for 10 min each, the membrane was finally incu-
bated for 1 h as above with 1:2000 dilution of alkaline
phosphatase-conjugated goat anti-mouse antibodies
(BioRad). After washing as above, bound enzyme-labeled
antibodies were detected with 5-bromo-4-chloro-3-in-
dolyl-phosphate (BCIP) and nitroblue tetrazolium (NBT)
substrate (Wako Bioproducts, Richmond, VA).
Time course of U27 protein expression
SupT1 cells (5 3 106) were infected with 103 tissue
ulture infectious dose 50 (TCID50) of HHV-7 and then
cultured in RPMI 1640 supplemented with 5% FCS. At 0,
24, 48, 72, and 96 h after infection, infected cells were
collected, washed with PBS, and lysed in a sample buffer
(0.1 M Tris–HCl, pH 6.8, 20% glycerol, 4% SDS, 5% b-mer-
aptoethanol, 0.2% bromphenal blue). After SDS–PAGE,
ollowed by transfer to PVDF membrane, the time course
f protein expression was determined by Western blot
nalysis.
HV-7 antigen expression in the presence of PFA
SupT1 cells were pretreated with PFA (500 mg/ml) for
1 h before infection or left untreated and then infected
with HHV-7. Infected cells were cultured in RPMI 1640
medium supplemented with 5% FCS in the presence or
absence of PFA for 72 h in a CO2 incubator. After sepa-ration of infected cell proteins by SDS–PAGE, Western
blotting was performed.
Preparation of nuclear and cytoplasmic fractions
Nuclear and cytoplasmic fractions were prepared as
described previously (Schreiber et al., 1989). Briefly,
HHV-7-infected SupT1 cells were washed with PBS and
resuspended in cold buffer A (10 mM HEPES, pH 7.9, 10
mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT), and
then Nonidet P-40 was added. After incubation for 15 min
on ice, the nuclear fraction was pelleted by centrifuga-
tion at 12,000 g for 30 s. The supernatant was used as
the cytoplasmic fraction.
Construction of HHV-7 U27 expression plasmids
The DNA fragment encoding the full-length HHV-7 U27
protein was amplified by PCR using primers 7U27-F1 and
7U27-R1. The viral DNA from strain KHR was used as the
template for PCR. The sequences of the above primers
were as follows: for 7U27-F1, 59-CAGGATCCATCTATTTT-
TGGTGCAGCATGG; and for 7U27-R1, 59-CAGAATTCCT-
TATGATTACATTCCACATCTTTG. The amplified fragment
was digested with BamHI and EcoRI and then inserted
into pcDNA3.1(1) (Invitrogen) to create the plasmid
pcDNA/7U27. The cloned DNA sequence was confirmed
by sequencing using the dideoxy chain-termination
method. The nucleotide sequence of strain KHR U27 was
completely identical to that published for strain JI (Nich-
olas, 1996).
To construct an expression plasmid for the His-Xpress
epitope-tagged C-terminal deletion mutant of the HHV-7
U27 protein, the DNA fragment was amplified by PCR
using the primers 7U27-F1 and 7U27-R4 (59-CAGAAT-
TCTTAACACGAAGACTTTAAAACTGC). Amplified DNA
fragments were digested with BamHI and EcoRI and
cloned into pcDNA3.1/HisC (Invitrogen). The resulting
plasmid, pHis/7U27(1-250), expresses the amino acid
sequence of HHV-7 U27 between residues 1 and 250. For
the expression of the His-Xpress epitope-tagged full-
length U27 protein, the DNA fragment from the plasmid
pcDNA/7U27 was recloned into the vector, pcDNA3.1/
HisC, yielding the plasmid pHis/7U27.
To construct plasmids pGFP/7U27(251-364), pGFP/
7U27(276-364), pGFP/7U27(301-364), pGFP/7U27(326-
364), and pGFP/7U27(351-364), various regions of HHV-7
U27 were amplified by PCR, digested with EcoRI and
BamHI, and then ligated into the expression vector,
pEGFP-C1 (Clontech, Palo Alto, CA). As forward primers,
7U27-F2 (59-CAGAATTCTAGTCTTAGAGCAATAGCTGGC),
7U27-F3 (59-CAGAATTCTTATTTAAGTCAAGAGCAG-
GTTAAAG), 7U27-F4 (59- CAGAATTCTAATCACAAGGTG-
GAGGAAGGA), 7U27-F5 (59-CAGAATTCTCCCACTA-
AAAATGGTGGCACAG), and 7U27-F6 (59- CAGAAT-
TCTTTTGACTATACCCCAAATTCGAAAAG) were used,
FF
F
400 TAKEDA ET AL.respectively. 7U27-R6 (59-CAGGATCCTGTATCGCTGAA-
GACACATGGC) was used as a common reverse primer.
To express the MBP fused to the C-terminus of the
HHV-7 U27 protein, the plasmid pMAL/7U27(251-364)
was constructed. Briefly, the DNA fragment encoding
amino acids 251–364 of the HHV-7 U27 protein was
amplified by PCR using primers MAL7U27-F and
MAL7U27-R. The amplified DNA fragment was digested
with EcoRI and PstI and then cloned into the plasmid
pMAL-c2 (New England Biolabs). The sequences of the
primers were 59- CAGAATTCAGTCTTAGAGCAATAGCT-
GGC for MAL7U27-F and 59- CACTGCAGTGTATCGCT-
GAAGACACATGGC for MAL7U27-R.
Microinjection
HeLa cells were grown onto glass coverslips in
DMEM supplemented with 5% FCS. Purified MBP- or
MBP/7U27(251-364)-fusion protein (2 mg/ml) was micro-
injected into the cell cytoplasm. After a 1-h incubation in
a CO2 incubator, cells were fixed in 3.7% formaldehyde,
permeabilized in 0.5% Triton X-100 in PBS, and then used
for IFA with anti-MBP antiserum (New England Biolabs).
For the experiments examining the inhibition of nuclear
translocation, WGA (2 mg/ml) or the Q69L Ran-GTP mu-
tant (4 mg/ml) was comicroinjected with the MBP-fusion
protein into the cell cytoplasm. MBP and the MBP-fusion
protein were purified using Amylose resin (New England
Biolabs) according to the instruction manual.
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